Doximity Stock Surges 90% After Strong Q1 Results and AI Progress
Investors sent Doximity’s stock to the moon after a clean Q1 revenue beat, higher guidance, and clear signs of AI product-market fit.
/ 6 items
#DOCS↓
OpenAI’s Free ChatGPT for Doctors Triggers Doximity Stock Slide
OpenAI launched ChatGPT for doctors to help with notes and research. It’s free in the US, boosts AI use, and Doximity stock fell.
Doximity Stock Plunges 30% on Weak Guidance and CFO Medical Leave
Doximity (DOCS) shares tumbled in premarket trading after the healthcare platform cut its revenue forecast and announced its CFO's temporary medical leave.
Wall Street Moves: Analysts Upgrade and Downgrade Key Tech Stocks
Morgan Stanley and KeyBanc updated their views on major tech stocks, upgrading Doximity, Asana, and Akamai, while downgrading ServiceNow and Adobe as part of their 2026 outlook.
Raymond James Upgrades Doximity to Strong Buy After Earnings Pullback
Raymond James upgrades Doximity to Strong Buy with a $65 target, citing an attractive risk/reward setup and improved long-term growth visibility despite a recent pullback.
BofA Boosts Doximity Rating as Drug Ad Strategy Changes
Bank of America raises Doximity to Buy with $82 target as pharma companies redirect ad spending from consumers to doctors amid new FDA regulations.